Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma

被引:46
|
作者
Bertini, I
Bianchini, F
Calorini, L
Colagrande, S
Fragai, M
Franchi, A
Gallo, O
Gavazzi, C
Luchinat, C
机构
[1] Univ Florence, Magnet Resonance Ctr, I-50019 Sesto Fiorentino, FI, Italy
[2] Univ Florence, Dept Chem, Florence, Italy
[3] Univ Florence, Dept Expt Pathol & Oncol, Florence, Italy
[4] Univ Florence, Dept Clin Physiopathol, Florence, Italy
[5] Univ Florence, Dept Human Pathol & Oncol, Florence, Italy
[6] Univ Florence, Dept Oto Neuroophthalmol Surg, Sch Med, Florence, Italy
[7] Univ Florence, Dept Agr Biotechnol, Florence, Italy
关键词
magnetic resonance imaging (MRI); liposome; melanoma; nuclear magnetic resonance dispersion (NMRD); contrast agents (CAs);
D O I
10.1002/mrm.20189
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In the present research, we investigated the use of paramagnetic liposomes as contrast agents (CAs) for the detection of solid tumors. The liposomes were sterically stabilized by a polyethylene glycol (PEG) coating, and their size was constrained to similar to100 nm. Dimyristoyl-sn-glycero-3-phosphoethanolamine-N-diethylene-triaminepentaacetate (DMPE-DTPA) was used as the gadolinium-carrying fatty acid chain. The relaxation properties were characterized through nuclear magnetic relaxation dispersion (NMRD) measurements, and analyzed with the use of theories and computer programs that are adequate for slowly rotating systems. Their relaxivity at 1.5 T was found to be acceptable for in vivo use. We then tested the liposomes against B16-F10 murine melanomas using standard T-1-weighted schemes at 1.5 T, and concentrations corresponding to 0.03 mmol/kg of gadolinium (i.e., three to six times lower than the concentration of the small gadolinium complexes in clinical use). The blood half-life was found to be 120 +/- 20 min. The experiments show a good contrast enhancement in the tumor (33% +/- 22%) 2 hr after administration, a further increase (43 +/- 27%) 20 hr after administration, and a decrease (25% +/- 14%) 54 hr after administration. High persistence of the CA was also observed in the liver and intestine, as expected in a hepatobiliar excretion pathway. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:669 / 672
页数:4
相关论文
共 50 条
  • [41] STERICALLY STABILIZED AMPHOTERICIN B-LIPOSOMES - TOXICITY AND BIODISTRIBUTION IN MICE
    VANETTEN, EWM
    VANVIANEN, W
    TIJHUIS, RHG
    STORM, G
    BAKKERWOUDENBERG, IAJM
    JOURNAL OF CONTROLLED RELEASE, 1995, 37 (1-2) : 123 - 129
  • [42] VERSATILITY IN LIPID COMPOSITIONS SHOWING PROLONGED CIRCULATION WITH STERICALLY STABILIZED LIPOSOMES
    WOODLE, MC
    MATTHAY, KK
    NEWMAN, MS
    HIDAYAT, JE
    COLLINS, LR
    REDEMANN, C
    MARTIN, FJ
    PAPAHADJOPOULOS, D
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1105 (02) : 193 - 200
  • [43] Doxorubicin in sterically stabilized liposomes (vol 380, pg 562, 1996)
    Lasic, DD
    NATURE, 1996, 381 (6583) : 630 - 630
  • [44] Interactions between nonionic surfactants and sterically stabilized phophatidyl choline liposomes
    Johnsson, M
    Edwards, K
    LANGMUIR, 2000, 16 (23) : 8632 - 8642
  • [45] Preparation, characterization, and pharmacokinetics of sterically stabilized nimodipine-containing liposomes
    Yang, DB
    Zhu, JB
    Zheng, Y
    Ge, L
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2006, 32 (02) : 219 - 227
  • [46] Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes
    Crosasso, P
    Ceruti, M
    Brusa, P
    Arpicco, S
    Dosio, F
    Cattel, L
    JOURNAL OF CONTROLLED RELEASE, 2000, 63 (1-2) : 19 - 30
  • [47] PHARMACOKINETICS AND ANTITUMOR-ACTIVITY OF VINCRISTINE ENCAPSULATED IN STERICALLY STABILIZED LIPOSOMES
    ALLEN, TM
    NEWMAN, MS
    WOODLE, MC
    MAYHEW, E
    USTER, PS
    INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (02) : 199 - 204
  • [48] Effect of multiple injections on pharmacokinetics and biodistribution of sterically stabilized liposomes.
    Dams, ETM
    Oyen, WJG
    Boerman, OC
    Laverman, P
    Storm, G
    van der Meer, JWM
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 242P - 242P
  • [49] LIPOSOMES CONTAINING PARAMAGNETIC MACROMOLECULES AS MRI CONTRAST AGENTS
    NAVON, G
    PANIGEL, R
    VALENSIN, G
    MAGNETIC RESONANCE IN MEDICINE, 1986, 3 (06) : 876 - 880
  • [50] PARAMAGNETIC LIPOSOMES AS MAGNETIC-RESONANCE CONTRAST AGENTS
    UNGER, E
    TILCOCK, C
    AHKONG, QF
    FRITZ, T
    INVESTIGATIVE RADIOLOGY, 1990, 25 : S65 - S66